Member Info for PDMSPiper

There are many shareholders who are rather resentful, angry and disappointed currently because they didn’t get their allocation in the placing.
Some will have been approached with the placing shortly after the “clearing the decks” trading update RNS, decided to take it and sold out in the 50’s thinking they would be able to replace their holding with 40p placing stock.
Unfortunately we little fish PIs are always at the back of the queue and from what I’m hearing most pi applications for the main placing were rejected and the iis took nearly all, apart from a few big, well connected private players.
Those PIs who sold tried to buy back in at low 40s on the drop but found it impossible to buy in size. They couldn’t load back up.
The price is now back where they sold or just under and so not worth them buying back in. They don’t even get the rights issue because they didn’t hold any on Friday.
They’re sore and now hoping for another drop to make it worthwhile them buying back in.

Design freeze due any day and they’re locked out due to greed. Never mind. We move on without them.

That was a great presentation. It’s looking even better than the most optimistic of us even thought. Keep your patience. Not long now.

GLA DYOR.

I’ll be sure to come and say hello to you on the VAL and TERN boards when we’re over a £1 Dibs. Shouldn’t be too long.

You’re sweating already. You’ll be gutted. Lol. Brilliant.

Omega have multiple income streams and it’s all set to happen in the next 2 or 3 weeks. What an exciting stick to hold.

My post that you have shown poor form has got 16 likes in 15 minutes Dibs. I’m afraid your credibility the board is now in tatters. I read everything you say now with the caveat that you want the company to fail.

Everybody sells and takes profit and moves on at some time but for you to now come back attempting to belittle the achievements of the company and ceo only since you sold is beneath contempt and shows no respect for existing or new shareholders

Youve taken your profit so move on. That’s how it works. New shareholders have taken your stock and with it they have taken on the risk and you have taken the money that they paid and banked it.

Have some humility and respect and don’t now come back to the board with rubbish about poor prospects when everyone can see that the prospects have improved considerably after the presentation and margin and capacity is even bigger than we thought.

Show some class Dibs and be happy and optimistic for new shareholders instead of displaying greed and malice. It isn’t a nice look. Enjoy the money. Good luck in the future.

“Between now and then i expect a steady flow of news with a rerate and consolidation at each level.”

I fully agree Merchant and furthermore, I expect the “Design Freeze” RNS will be more than just that. I’m expecting details on connectivity, rollout and initial orders.
I always said if we can make fifty million tests a year and sell them then the rerate of that income will take the company to £300Million Mcap and now that looks ever more certain.
The placees will have been given that presentation also so it’s no wonder it was over subscribed.

Investment further derisked again. People were paying 87 after the Sky interview and now we know more. Details of the gov travel strategy due very soon also. John Holland Kaye, Heathrow CEO wants to implement antibody testing and I’ve seen his statements on that and heard him say as much in the bbc radio 4 interview. Priti Patel has also said Rapid Antibody testing will be used to remove the quarantine.
As previously discussed this news will be all over the front pages, bbc and sky news within days. It isn’t just design freeze, the big news will be the removal of the quarantine using the news measures to be introduced, one of which will be implementing the new initiative of the gov RTC antibody test which Boris will claim as his master stroke.

Pubs open by July 4. Campsites open by July 4. Travel restrictions and quarantine removed by July 4 also is my prediction and an announcement of the use of the antibody tests in the briefing days after design freeze.

Front pages here we come. Make no mistake. This will be big news. GLA.

Very poor form for you to come back here bashing the prospects after taking your profit and banking your gains Dibs. Very poor form.

I’d thought you were better than that. Disappointing.

Just for transparency Dibs: You posted you’d sold out. That’s fine. You’re now back posting negativity. That caveat needs to be added.

Good luck in your future investments.

And I’m off to the gym and the beach.

If it goes down I’m happy, got £20k worth of limit buy orders set in the 40’s across different accounts. If it goes up I’m happy as the main holding will be booming.

Happy days. As Sir Dominic says, be like Fonzy.

GLA.

Goals from all over the park in Elisa, LF, Antigen and Antibody, plus all the other non Covid business that will now benefit from more investment and more rapid scale up and more marketing.

Omega is going places. Looks like a £300Million Mcap is very likely by later in the year.

I’ll be hanging around.

From 9th April RNS....

“The MOU is for an initial period of six months and the Parties will collaborate to utilise their combined lateral flow test design and manufacturing expertise to optimise the design for potential accelerated scale-up to manufacturing of the COVID-19 Rapid Test.

Once the COVID-19 Rapid Test reaches design freeze, then the specification and standard operating procedures will be shared with each party of the consortium to enable manufacturing and/or assembly to be undertaken at each site, including at Omega's manufacturing facility in Alva, Scotland, according to capability.”

The development is funded by UK Gov. I haven’t seen anything in writing to say that Abingdon own the rights to the test after design freeze.

Can you post a link to that information please Phoenix. I’d be interested to read it. Thanks.

Nice summary Phoenix.

This part...... “Now what remains to be seen is if Abingdon Health will extend the partnership and sell these tests outside the framework of U.K. RTC to rest of the world.“

As far as I understand it Abingdon are lead partner but they will not own the IP or have any control over the tech after design freeze.

According to the RNS the spec will be shared with all partners and ODX will be free to commercialize as they see fit.
No doubt they will have to fulfill the initial gov orders first but after that there is no impediment to ODX marketing the tests globally through their existing global contact channels set up to market the visitect cd4 tests.

As far as I understand it, Abingdon won’t have any say at all in how the other partners choose to commercialize. They are lead partners for development only. Once we’re in production, it’s every man for himself.

Yes it’s one share for every 20 you held at close of play on Friday.

So if you held 100 shares, its 100/20, so you can buy another 5 for 40p each. I.e. 5 per 100, 100 being cent in Latin, five per cent, 5% extra allocation, one in twenty.

You’re welcome. Lol.

Have I misunderstood what you posted then?

Your post here suggests that you think the gov scientific advisors and strategy team are all wrong and the investors on this board are right....

“Was that post rhetorical?

Antibody testing is pointless if you’re trying to stop the spread. It’s also littered with issues, poor sampling, antibodies not being generated until day 5 or 9 and maybe not at all for asymptomatic people. Nothing is perfect, but Awacta’s test will be as close as you can get for mass screening. Our miserable friend Klaus at Cytiva suggested over 95% would be valuable and hinted higher is what they’re aiming for, Awacta then confirmed they knew they could produce it.

I have no concern at all as an investor that the govt are making poor decisions. It’s not great for the population though.“

Isn’t that what you’re saying? Whitty, Bell and the advisors know less than you?

If that’s not what you meant to say then what do you mean?

Why have the Gov not bothered to develop an accurate rapid antigen test? Why have they only put effort into developing a rapid antibody test?

If you read this board then you lot know more than the gov advisors and you think they’re going to come to their senses and change their strategy. Is that correct?

So PL75, you think it’s because Professor Whitty, Professor John Bell and the life sciences teams at Oxford and Cambridge Unis are all a bit thick and missing a trick. I see. Right o.

Do you think the Government are just happy with progress on the Avacta/Cytiva test and are just ignoring the antigen development side of things because it’s all boxed off.
Maybe Gov and Cytiva have done a deal already and its all boxed off. I see. Right o. I’ll look into it.

“many will offload first thing on Monday having qualified for the offer.”

There’s only £3 mill quid in the open offer. Maybe half might offload, half will hold, so £1.5 might churn. It’s not exactly huge. We’ve had several big 20 and 30 mill volume days and average vol has been about 7 mill I think, though correct me if I’m wrong as I’ve not bothered looking at volume for a while.
In any case it’s not much but MMs could take advantage of it to drop the price.
Nothing’s guaranteed. It would be interesting to see what they do but I won’t be watching it. I’ll have buy limit orders set to try and pick up some cheapies if it goes down there near placing price but apart from that I’m not fussed. I’ll be out and about doing my normal stuff and chilled until news.
Just set orders for buys or sells of whatever you want to do and forget it. Works for me.

Why do you think the Government formed a rapid test consortium made up of 4 specialist U.K. biotech companies and Oxford University to produce a rapid antibody test but not an antigen test?

I can’t understand it? Why did they not set up one for the Antigen test as well. There isn’t one available, so why not?

Is it because the strategy they plan to employ doesn’t need one? Or is it because Professor Whitty, Professor John Bell and the life sciences teams at Oxford and Cambridge Unis are all a bit thick and missing a trick? What d’ya reckon?

The accuracy bar for mass screening of a population or at airports etc is 98%.

Is that what shareholders are expecting? A saliva based rapid antigen test that is over 98% accurate?

Abingdon Health are also a Northern Company, based in York and they specialize in lateral flow test poc devices. Look at the website.

https://www.abingdonhealth.com/contract-services/

The 20 minute Antigen test being trialled is Optigene......

https://www.gov.uk/government/news/trial-of-rapid-coronavirus-test-launched-in-hampshire

Next...

Safy. I’m not nervous. I’m not concerned.

If it drops to 45 I’ll buy.

The point of the post was to alert tonthe possibility and those that want to buy some stock lower then have cash on account ready because placing flippers could provide that opportunity next week.

Be ready for it. Good luck.

No, they are not recruiting for Avacta LFA scientists.

They are recruiting for Lateral Flow specialists for Abingdon Health in York, as part of the scale up for the Rapid Test Consortium Antibody Test. Abingdon are a member of the consortium with Omega Diagnostics.

The job ad is here...

https://www.abingdonhealth.com/wp-content/uploads/2020/03/Lateral-Flow-Assay-Development-Scientists-Mar-2020.pdf

I’m not aware of others in Yorkshire. Other scientists are being recruited for omegas expansion in Alva, Scotland.